Proteomic analysis of colonic myofibroblasts and effect on colon cancer cell proliferation

Cunha, 1985, Stromal-epithelial interactions in adult organs, Cell Differ, 17, 137, 10.1016/0045-6039(85)90481-6 Ronnov-Jessen, 1996, Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction, Physiol Rev, 76, 69, 10.1152/physrev.1996.76.1.69 Erickson, 2003, The not-so innocent bystander: the microenvironment as a therapeutic target in cancer, Expert Opin Ther Targets, 7, 71, 10.1517/14728222.7.1.71 Thiery, 2002, Epithelial-mesenchymal transitions in tumour progression, Nat Rev Cancer, 2, 442, 10.1038/nrc822 Elenbaas, 2001, Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation, Exp Cell Res, 264, 169, 10.1006/excr.2000.5133 Bhowmick, 2004, TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia, Science, 303, 848, 10.1126/science.1090922 Powell, 1999, Myofibroblasts, II: intestinal subepithelial myofibroblasts, Am J Physiol, 277, C183, 10.1152/ajpcell.1999.277.2.C183 Adegboyega, 2002, Immunohistochemical study of myofibroblasts in normal colonic mucosa, hyperplastic polyps, and adenomatous colorectal polyps, Arch Pathol Lab Med, 126, 829, 10.5858/2002-126-0829-ISOMIN Wang QWX, Hernandez A, Hellmich MR, Gatalica Z, Evers BM. Regulation of TRAIL expression by the phosphatidylinositol 3-kinase/Akt/GSK-3 pathway in human colon cancer cells. J Biol Chem 2002;277:36602-10. Horowitz, 2004, Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor-beta1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor, J Biol Chem, 279, 1359, 10.1074/jbc.M306248200 Kobayashi, 1999, Dedifferentiation of adenocarcinomas by activation of phosphatidylinositol 3-kinase, Proc Natl Acad Sci USA, 96, 4874, 10.1073/pnas.96.9.4874 Phillips, 1998, Increased levels of phosphatidylinositol 3-kinase activity in colorectal tumors, Cancer, 83, 41, 10.1002/(SICI)1097-0142(19980701)83:1<41::AID-CNCR6>3.0.CO;2-H Datta, 1997, Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery, Cell, 91, 231, 10.1016/S0092-8674(00)80405-5 Calvert, 2002, The genetics of colorectal cancer, Ann Intern Med, 137, 603, 10.7326/0003-4819-137-7-200210010-00012 Sugiyama, 2005, Analysis of differential gene expression patterns in colon cancer and cancer stroma using microdissected tissues, Gastroenterology, 128, 480, 10.1053/j.gastro.2004.11.010 Mahida, 1997, Adult human colonic subepithelial myofibroblasts express extracellular matrix proteins and cyclooxygenase-1 and -2, Am J Physiol, 273, G1341 Bradford, 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal Biochem, 72, 248, 10.1016/0003-2697(76)90527-3 Wang QLN, Wang X, Kim MM, Evers BM. Augmentation of sodium butyrate-induced apoptosis by phosphatidylinositol 3′-kinase inhibition in the KM20 human colon cancer cell line. Clin Cancer Res 2002;8:1940-7. Mills, 2003, Linking molecular diagnostics to molecular therapeutics: targeting the PI3K pathway in breast cancer, Semin Oncol, 30, 93, 10.1053/j.seminoncol.2003.08.011 Paterson, 2003, Molecular genetic alterations in the laser-capture-microdissected stroma adjacent to bladder carcinoma, Cancer, 98, 1830, 10.1002/cncr.11747 Kurose, 2002, Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas, Nat Genet, 32, 355, 10.1038/ng1013 Cunha, 2003, Role of the stromal microenvironment in carcinogenesis of the prostate, Int J Cancer, 107, 1, 10.1002/ijc.11335 Wang, 2001, Inhibition of the phosphatidylinositol 3-kinase pathway contributes to HT29 and Caco-2 intestinal cell differentiation, Gastroenterology, 120, 1381, 10.1053/gast.2001.24044 Tang, 2004, Current developments in SELDI affinity technology, Mass Spectrom Rev, 23, 34, 10.1002/mas.10066 Shiwa, 2003, Rapid discovery and identification of a tissue-specific tumor biomarker from 39 human cancer cell lines using the SELDI ProteinChip platform, Biochem Biophys Res Commun, 309, 18, 10.1016/S0006-291X(03)01520-1